Cancer startup: Drug development company acquires OHSU’s MolecularMD

ICON buys molecular diagnostic specialty lab co-founded by prominent OHSU scientists

By Amanda Gibbs March 27, 2019 Portland, Oregon

Downloads

Brian Druker, M.D. (2017)

Brian Druker, M.D., Knight Cancer Institute director, JELD-WEN Chair of Leukemia Research; investigator, Howard Hughes Medical Institute. (OHSU/Kristyna Wentz-Graff)

Michael Heinrich, M.D.

Michael Heinrich, M.D., professor in the division of hematology and medical oncology at the OHSU Knight Cancer Institute; physician at the Portland Veterans Affairs Medical Center, November 1, 2017. (OHSU/Kristyna Wentz-Graff)